Delcath Systems - 2002 News Archive

2002 Archive

January 16, 2002
Phase III Trial For Delcath Drug Delivery System Planned At New York University Medical School

April 3, 2002
Delcath Systems' Phase III Trial for Inoperable Cancer Is Planned At Sydney Melanoma Unit

May 2, 2002
Delcath Names New Auditor, and Confirms No Accounting Issues With KPMG LLP

May 24, 2002
Delcath Re-elects Two Directors at 2002 Annual Meeting

August 12, 2002
Delcath Issues First Half 2002 Report to Shareholders

October 1, 2002
DELCATH APPROVES STOCK REPURCHASE PROGRAM

December 9, 2002
DELCATH ANNOUNCES A PUBLIC OFFERING OF SECURITIES

December 11, 2002
NATIONAL CANCER INSTITUTE STUDY WITH DELCATH SYSTEM SHOWS EARLY PROMISE

Delcath News

June 13, 2007
Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors

June 5, 2007
Delcath Updates Clinical Trials

June 5, 2007
Jonathan J. Lewis, MD Joins Delcath's Board of Directors

May 30, 2007

Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center

May 24, 2007

Delcath Systems Names Laura A. Philips to Board of Directors

May 24, 2007

Delcath Systems Adds Two Executives

May 17, 2007

Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology

May 16, 2007
Delcath Systems Issues CEO Letter to Shareholders

May 10, 2007
DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION

April 17, 2007
Delcath Systems Announces Board Resignations

April 10, 2007
DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

Stock Quote

Delcath stock tracker

Most recent trade:$1.22

Today's Change:0.00

(Prices delayed up to 20 minutes.)